Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin for Glycemic Control in Hospitalized Patients
NCT02182895Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jul 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Brigham and Women's Hospital. Started Jul 2014; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02182895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182895.